|
1
|
Toss A, Mu Z, Fernandez S and
Cristofanilli M: CTC enumeration and characterization: Moving
toward personalized medicine. Ann Transl Med. 2:1082014.PubMed/NCBI
|
|
2
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW, et al: Circulating tumor cells, disease progression,
and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka F, Yoneda K, Kondo N, Hashimoto M,
Takuwa T, Matsumoto S, Okumura Y, Rahman S, Tsubota N, Tsujimura T,
et al: Circulating tumor cell as a diagnostic marker in primary
lung cancer. Clin Cancer Res. 15:6980–6986. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsiouris A and Walesby RK: Malignant
pleural mesothelioma: Current concepts in treatment. Nat Clin Pract
Oncol. 4:344–352. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoneda K, Tanaka F, Kondo N, Hashimoto M,
Takuwa T, Matsumoto S, Okumura Y, Tsubota N, Sato A, Tsujimura T,
et al: Circulating tumor cells (CTCs) in malignant pleural
mesothelioma (MPM). Ann Surg Oncol. 21:(Suppl 4). 472–480. 2014.
View Article : Google Scholar
|
|
9
|
Joosse SA, Gorges TM and Pantel K:
Biology, detection, and clinical implications of circulating tumor
cells. EMBO Mol Med. 7:1–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maheswaran S, Sequist LV, Nagrath S, Ulkus
L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ,
Bell DW, et al: Detection of mutations in EGFR in circulating
lung-cancer cells. N Engl J Med. 359:366–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohnaga T, Shimada Y, Moriyama M, Kishi H,
Obata T, Takata K, Okumura T, Nagata T, Muraguchi A and Tsukada K:
Polymeric microfluidic devices exhibiting sufficient capture of
cancer cell line for isolation of circulating tumor cells. Biomed
Microdevices. 15:611–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Usami N, Fukui T, Kondo M, Taniguchi T,
Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, et al:
Establishment and characterization of four malignant pleural
mesothelioma cell lines from Japanese patients. Cancer Sci.
97:387–394. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Husain AN, Colby TV, Ordóñez NG, Krausz T,
Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs
AR, et al: Guidelines for pathologic diagnosis of malignant
mesothelioma: A consensus statement from the International
Mesothelioma Interest Group. Arch Pathol Lab Med. 133:1317–1331.
2009.PubMed/NCBI
|
|
15
|
Sato A, Torii I, Okamura Y, Yamamoto T,
Nishigami T, Kataoka TR, Song M, Hasegawa S, Nakano T, Kamei T, et
al: Immunocytochemistry of CD146 is useful to discriminate between
malignant pleural mesothelioma and reactive mesothelium. Mod
Pathol. 23:1458–1466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ilie M, Hofman V, Long E, Bordone O, Selva
E, Washetine K, Marquette CH and Hofman P: Current challenges for
detection of circulating tumor cells and cell-free circulating
nucleic acids, and their characterization in non-small cell lung
carcinoma patients. What is the best blood substrate for
personalized medicine? Ann Transl Med. 2:1072014.PubMed/NCBI
|
